查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828935

2034 年抗肥胖藥物市場分析與預測：類型、產品、服務、技術、組件、應用、形式、最終用戶、設備和模式

Anti Obesity Drugs Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Form, End User, Device, Mode
出版日期: | 出版商: Global Insight Services | 英文 331 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計減重藥物市場規模將從2024年的172億美元增加至2034年的1,641億美元，複合年成長率約為25.3%。減肥藥市場涵蓋透過降低食慾、促進新陳代謝和抑制脂肪吸收來幫助減肥的藥物。肥胖率上升、生活方式改變以及健康意識增強是推動該市場發展的因素。技術創新著重療效、安全性和最小化副作用，而監理機關的核准則決定市場動態。策略夥伴關係和研發投入對於應對全球肥胖症流行至關重要，並能帶來巨大的成長機會。

受肥胖率上升和健康風險意識增強的推動，減肥藥物市場正在經歷顯著成長。藥物治療領域以 GLP-1 受體促效劑為主導，其可有效控制體重並改善代謝。緊隨其後的是複方藥物，它們具有協同作用，可改善患者的預後。由於醫生的建議和經過驗證的臨床結果，處方藥細分市場正在超越非處方藥。腸道微生物組調節劑等新治療方法作為減重的新方法正受到關注。透過解決兒童肥胖問題，兒童減肥藥物領域也預計將成長。包括口服和注射製劑在內的藥物傳遞系統的創新正在提高患者的依從性並擴大市場吸引力。個人化醫療利用基因圖譜來指導客製化治療策略，正變得越來越重要。在製藥業持續的研發努力和策略夥伴關係關係的支持下，市場可望擴張。

市場區隔
類型 處方藥、非處方藥和草藥補充劑
產品 食慾抑制劑、代謝促進劑、脂肪吸收抑制劑、組合藥物
服務 諮詢服務、體重管理計劃、生活方式諮詢
科技 藥物基因體學、奈米技術、生物技術
成分 活性藥物成分、輔料
目的 慢性肥胖、體重管理
劑型 藥片、膠囊、液體劑、注射劑
最終用戶 醫院、診所、居家照護機構和健康中心
裝置 醫療設備、穿戴式裝置
模式 口服和注射藥物

市場概述

隨著多家公司推出創新產品，減重藥物市場正經歷動態的市場佔有率變化。定價策略保持競爭力，反映了對有效體重管理解決方案的需求。新產品的推出著重於先進的配方和給藥機制，從而引起了消費者日益成長的興趣。市場正見證著個人化醫療的趨勢，公司投資於研發以提供量身定做的解決方案。競爭性基準化分析凸顯了主要企業利用策略合作夥伴關係和收購來加強其市場地位的優勢。法規具有重大影響，嚴格的指導方針影響醫藥品認證過程。然而，這些法規也確保了高安全性和有效性標準，增強了消費者信心。該市場的特點是技術進步迅速，人工智慧和數據分析在藥物開發中發揮關鍵作用。在全球範圍內，採用率各不相同，以北美和歐洲為首，但新興市場提供了尚未開發的成長潛力。

主要趨勢和促進因素：

受肥胖率上升和健康風險意識增強的推動，減肥藥市場正經歷強勁成長。藥物開發技術的進步帶來了更有效、副作用更少的治療方法，從而推動了市場擴張。生活型態的改變和久坐習慣導致肥胖率上升，需要藥物介入。政府提倡的體重管理和肥胖預防措施和醫療政策進一步推動了市場發展。對個人化醫療的需求推動了標靶治療的創新，提高了藥物療效和患者預後。此外，數位健康工具的整合支持患者的依從性和監測，提高了治療成功率。由於醫療基礎設施的不斷成長和可支配收入的增加，新興市場提供了豐厚的商機。製藥公司之間的策略聯盟與合作正在推動研發，並加速新型減肥藥的推出。隨著人們對肥胖相關併發症的認知不斷提高，市場有望實現持續成長，重點是以患者為中心、提供整體解決方案。

限制與挑戰：

目前，減肥藥市場面臨幾項重大的市場限制和挑戰。一個關鍵的限制因素是嚴格的法規環境，它要求嚴格的核准流程並延遲新藥的上市。這種監管的複雜性往往意味著製藥公司的成本增加和時間延長。另一個挑戰是藥物開發和商業化成本高，抑制了投資和創新。許多公司在試圖將新型減肥解決方案推向市場時面臨財務障礙。此外，與肥胖相關的持續存在的恥辱感導致患者依從性低且不願接受治療，從而削弱了市場潛力。此外，目前減肥藥的療效有限且副作用大，也構成了市場障礙，往往無法滿足患者和醫生的期望。最後，人們越來越重視生活方式和飲食干預作為第一線治療，這進一步降低了對藥物解決方案的需求，影響了市場成長。

關鍵人物

Orexigen Therapeutics、Vivus、Arena Pharmaceuticals、Zafgen、Rhythm Pharmaceuticals、Novo Nordisk、Gelesis、Eisai Co Ltd、Alizyme Therapeutics、NeuroSearch、Sorrento Therapeutics、Amgen、Allergan、Saniona、8i Ventures

目錄

第1章 抗肥胖藥物市場概述

  • 調查目的
  • 抗肥胖藥物市場定義與研究範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章：重要考察

第4章：抗肥胖藥物市場展望

  • 抗肥胖藥物市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章：抗肥胖藥物市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章：減肥藥市場規模

  • 抗肥胖藥物市場規模：以金額為準
  • 抗肥胖藥物市場規模

第7章：按類型分類的抗肥胖藥物市場

  • 市場概況
  • 處方藥
  • 非處方藥
  • 草藥補充劑
  • 其他

第 8 章：抗肥胖藥物市場（按產品）

  • 市場概況
  • 食慾抑制劑
  • 代謝加速器
  • 脂肪吸收抑制劑
  • 組合藥物
  • 其他

第9章 抗肥胖藥物市場（按服務）

  • 市場概況
  • 諮詢服務
  • 體重管理計劃
  • 生活方式諮詢
  • 其他

第 10 章。按技術分類的抗肥胖藥物市場

  • 市場概況
  • 藥物基因體學
  • 奈米科技
  • 生物技術
  • 其他

第 11 章 抗肥胖藥物市場（依成分）

  • 市場概況
  • 原料藥
  • 輔料
  • 其他

第 12 章：抗肥胖藥物市場（依應用）

  • 市場概況
  • 慢性肥胖
  • 體重管理
  • 其他

第13章 抗肥胖藥物市場（依形式）

  • 市場概況
  • 藥片
  • 膠囊
  • 液體
  • 注射
  • 其他

第 14 章。 抗肥胖藥物市場（按最終用戶）

  • 市場概況
  • 醫院
  • 診所
  • 居家醫療
  • 健康中心
  • 其他

第 15 章。按設備分類的抗肥胖藥物市場

  • 市場概況
  • 醫療設備
  • 穿戴式裝置
  • 其他

第16章。 抗肥胖藥物市場（按模式）

  • 市場概況
  • 口服
  • 注射
  • 其他

第 17 章：按地區分類的抗肥胖藥物市場

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市佔率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章：公司簡介

  • Orexigen Therapeutics
  • Vivus
  • Arena Pharmaceuticals
  • Zafgen
  • Rhythm Pharmaceuticals
  • Novo Nordisk
  • Gelesis
  • Eisai Co Ltd
  • Alizyme Therapeutics
  • NeuroSearch
  • Sorrento Therapeutics
  • Amgen
  • Allergan
  • Saniona
  • 8i Ventures
簡介目錄
Product Code: GIS33623

Anti Obesity Drugs Market is anticipated to expand from $17.2 billion in 2024 to $164.1 billion by 2034, growing at a CAGR of approximately 25.3%. The Anti Obesity Drugs Market encompasses pharmaceuticals designed to aid weight loss by reducing appetite, increasing metabolism, or inhibiting fat absorption. This market is driven by rising obesity rates, lifestyle changes, and increasing health awareness. Innovations focus on efficacy, safety, and minimal side effects, with regulatory approvals shaping market dynamics. Strategic partnerships and research investments are pivotal in addressing the global obesity epidemic, offering significant growth opportunities.

The Anti-Obesity Drugs Market is experiencing significant growth, propelled by rising obesity rates and increased awareness of health risks. The pharmacotherapy segment dominates, with GLP-1 receptor agonists leading due to their efficacy in weight management and metabolic improvement. Following closely are combination drugs, which offer synergistic effects and enhanced patient outcomes. The prescription drugs sub-segment outperforms over-the-counter options, driven by physician recommendations and proven clinical results. Emerging therapies, such as gut microbiome modulators, are gaining attention for their novel approach to weight loss. The pediatric anti-obesity drugs segment is also expected to grow, addressing childhood obesity concerns. Innovations in drug delivery systems, including oral and injectable formulations, enhance patient compliance and broaden market appeal. Personalized medicine is becoming increasingly relevant, with genetic profiling guiding tailored therapeutic strategies. The market is poised for expansion, supported by ongoing research and development efforts and strategic partnerships in the pharmaceutical industry.

Market Segmentation
TypePrescription Drugs, Over-the-Counter Drugs, Herbal Supplements
ProductAppetite Suppressants, Metabolic Enhancers, Fat Absorption Inhibitors, Combination Drugs
ServicesConsultation Services, Weight Management Programs, Lifestyle Counseling
TechnologyPharmacogenomics, Nanotechnology, Biotechnology
ComponentActive Pharmaceutical Ingredients, Excipients
ApplicationChronic Obesity, Weight Management
FormTablets, Capsules, Liquid, Injectables
End UserHospitals, Clinics, Home Care Settings, Wellness Centers
DeviceMedical Devices, Wearable Devices
ModeOral, Injectable

Market Snapshot:

The Anti Obesity Drugs Market is experiencing a dynamic shift in market share, with several companies introducing innovative products. Pricing strategies remain competitive, reflecting the demand for effective weight management solutions. New product launches are focusing on advanced formulations and delivery mechanisms, contributing to heightened consumer interest. The market is witnessing a trend towards personalized medicine, with companies investing in research and development to offer tailored solutions. Competition benchmarking highlights the dominance of key players who are leveraging strategic partnerships and acquisitions to enhance their market position. Regulatory influences are significant, with stringent guidelines affecting drug approval processes. However, these regulations also ensure high safety and efficacy standards, fostering consumer trust. The market is characterized by rapid technological advancements, with AI and data analytics playing crucial roles in drug development. The global landscape shows varying adoption rates, with North America and Europe leading, while emerging markets present untapped potential for growth.

Geographical Overview:

The anti-obesity drugs market is witnessing notable growth across diverse regions, each exhibiting unique characteristics. North America dominates the market, propelled by escalating obesity rates and robust healthcare infrastructure. The region's focus on innovative drug development and supportive regulatory frameworks further bolsters its market leadership. Europe follows, driven by increasing health consciousness and government initiatives to curb obesity prevalence. The region benefits from a strong pharmaceutical industry and collaborative research efforts. In the Asia Pacific, the market is expanding rapidly, driven by rising obesity rates and increasing healthcare expenditure. Countries like China and India are emerging as significant growth pockets due to their large population base and improving healthcare access. Latin America and the Middle East & Africa are also witnessing growth, albeit at a slower pace. In these regions, rising awareness and government initiatives to combat obesity are creating new opportunities for market expansion.

Key Trends and Drivers:

The Anti-Obesity Drugs Market is experiencing robust growth fueled by rising obesity rates and increasing awareness of health risks. Technological advancements in drug development have led to more effective treatments with fewer side effects, driving market expansion. Lifestyle changes and sedentary habits are contributing to higher obesity prevalence, necessitating pharmaceutical interventions. Government initiatives and healthcare policies promoting weight management and obesity prevention are further propelling the market. The demand for personalized medicine is encouraging innovation in targeted therapies, enhancing drug efficacy and patient outcomes. Additionally, the integration of digital health tools is supporting patient adherence and monitoring, bolstering treatment success. Emerging markets present lucrative opportunities due to growing healthcare infrastructure and rising disposable incomes. Strategic partnerships and collaborations among pharmaceutical companies are fostering research and development, accelerating the introduction of novel anti-obesity drugs. As awareness of obesity-related complications increases, the market is poised for sustained growth, with a focus on holistic and patient-centric solutions.

Restraints and Challenges:

The Anti-Obesity Drugs Market is currently confronted with several significant restraints and challenges. A primary restraint is the stringent regulatory environment, which imposes rigorous approval processes, delaying the introduction of new drugs to the market. This regulatory complexity often results in increased costs and extended timelines for pharmaceutical companies. Another challenge is the high cost of drug development and commercialization, which can deter investment and innovation. Many companies face financial barriers when attempting to bring novel anti-obesity solutions to market. Additionally, there is a persistent stigma associated with obesity, leading to low patient adherence and reluctance to seek treatment, which undermines market potential. Moreover, the market is hindered by the limited efficacy and side effects of current anti-obesity medications, which often fail to meet patient and physician expectations. Lastly, the growing emphasis on lifestyle and dietary interventions as first-line treatments further diminishes the demand for pharmacological solutions, impacting market growth.

Key Players:

Orexigen Therapeutics, Vivus, Arena Pharmaceuticals, Zafgen, Rhythm Pharmaceuticals, Novo Nordisk, Gelesis, Eisai Co Ltd, Alizyme Therapeutics, NeuroSearch, Sorrento Therapeutics, Amgen, Allergan, Saniona, 8i Ventures

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Anti Obesity Drugs Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Anti Obesity Drugs Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by Form
  • 2.10 Key Highlights of the Market, by End User
  • 2.11 Key Highlights of the Market, by Device
  • 2.12 Key Highlights of the Market, by Mode
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by Form
  • 3.9 Market Attractiveness Analysis, by End User
  • 3.10 Market Attractiveness Analysis, by Device
  • 3.11 Market Attractiveness Analysis, by Mode
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Anti Obesity Drugs Market Outlook

  • 4.1 Anti Obesity Drugs Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Anti Obesity Drugs Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Anti Obesity Drugs Market Size

  • 6.1 Anti Obesity Drugs Market Size, by Value
  • 6.2 Anti Obesity Drugs Market Size, by Volume

7: Anti Obesity Drugs Market, by Type

  • 7.1 Market Overview
  • 7.2 Prescription Drugs
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Over-the-Counter Drugs
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Herbal Supplements
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Anti Obesity Drugs Market, by Product

  • 8.1 Market Overview
  • 8.2 Appetite Suppressants
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Metabolic Enhancers
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fat Absorption Inhibitors
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Combination Drugs
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Anti Obesity Drugs Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation Services
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Weight Management Programs
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Lifestyle Counseling
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Anti Obesity Drugs Market, by Technology

  • 10.1 Market Overview
  • 10.2 Pharmacogenomics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Nanotechnology
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Biotechnology
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Anti Obesity Drugs Market, by Component

  • 11.1 Market Overview
  • 11.2 Active Pharmaceutical Ingredients
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Excipients
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Others
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region

12: Anti Obesity Drugs Market, by Application

  • 12.1 Market Overview
  • 12.2 Chronic Obesity
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Weight Management
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Anti Obesity Drugs Market, by Form

  • 13.1 Market Overview
  • 13.2 Tablets
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Capsules
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Liquid
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Injectables
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Others
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region

14: Anti Obesity Drugs Market, by End User

  • 14.1 Market Overview
  • 14.2 Hospitals
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinics
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Home Care Settings
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Wellness Centers
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Anti Obesity Drugs Market, by Device

  • 15.1 Market Overview
  • 15.2 Medical Devices
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Wearable Devices
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Anti Obesity Drugs Market, by Mode

  • 16.1 Market Overview
  • 16.2 Oral
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Injectable
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Anti Obesity Drugs Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Component
    • 17.2.7 North America Market Size and Forecast, by Application
    • 17.2.8 North America Market Size and Forecast, by Form
    • 17.2.9 North America Market Size and Forecast, by End User
    • 17.2.10 North America Market Size and Forecast, by Device
    • 17.2.11 North America Market Size and Forecast, by Mode
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Component
      • 17.2.9.6 United States Market Size and Forecast, by Application
      • 17.2.9.7 United States Market Size and Forecast, by Form
      • 17.2.9.8 United States Market Size and Forecast, by End User
      • 17.2.9.9 United States Market Size and Forecast, by Device
      • 17.2.9.10 United States Market Size and Forecast, by Mode
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Component
      • 17.2.10.6 Canada Market Size and Forecast, by Application
      • 17.2.10.7 Canada Market Size and Forecast, by Form
      • 17.2.10.8 Canada Market Size and Forecast, by End User
      • 17.2.10.9 Canada Market Size and Forecast, by Device
      • 17.2.10.10 Canada Market Size and Forecast, by Mode
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Component
    • 17.3.7 Europe Market Size and Forecast, by Application
    • 17.3.8 Europe Market Size and Forecast, by Form
    • 17.3.9 Europe Market Size and Forecast, by End User
    • 17.3.10 Europe Market Size and Forecast, by Device
    • 17.3.11 Europe Market Size and Forecast, by Mode
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.8 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Component
      • 17.3.10.6 Germany Market Size and Forecast, by Application
      • 17.3.10.7 Germany Market Size and Forecast, by Form
      • 17.3.10.8 Germany Market Size and Forecast, by End User
      • 17.3.10.9 Germany Market Size and Forecast, by Device
      • 17.3.10.10 Germany Market Size and Forecast, by Mode
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Component
      • 17.3.11.6 France Market Size and Forecast, by Application
      • 17.3.11.7 France Market Size and Forecast, by Form
      • 17.3.11.8 France Market Size and Forecast, by End User
      • 17.3.11.9 France Market Size and Forecast, by Device
      • 17.3.11.10 France Market Size and Forecast, by Mode
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Component
      • 17.3.12.6 Spain Market Size and Forecast, by Application
      • 17.3.12.7 Spain Market Size and Forecast, by Form
      • 17.3.12.8 Spain Market Size and Forecast, by End User
      • 17.3.12.9 Spain Market Size and Forecast, by Device
      • 17.3.12.10 Spain Market Size and Forecast, by Mode
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Component
      • 17.3.13.6 Italy Market Size and Forecast, by Application
      • 17.3.13.7 Italy Market Size and Forecast, by Form
      • 17.3.13.8 Italy Market Size and Forecast, by End User
      • 17.3.13.9 Italy Market Size and Forecast, by Device
      • 17.3.13.10 Italy Market Size and Forecast, by Mode
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Component
      • 17.3.14.6 Netherlands Market Size and Forecast, by Application
      • 17.3.14.7 Netherlands Market Size and Forecast, by Form
      • 17.3.14.8 Netherlands Market Size and Forecast, by End User
      • 17.3.14.9 Netherlands Market Size and Forecast, by Device
      • 17.3.14.10 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Component
      • 17.3.15.6 Sweden Market Size and Forecast, by Application
      • 17.3.15.7 Sweden Market Size and Forecast, by Form
      • 17.3.15.8 Sweden Market Size and Forecast, by End User
      • 17.3.15.9 Sweden Market Size and Forecast, by Device
      • 17.3.15.10 Sweden Market Size and Forecast, by Mode
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Component
      • 17.3.16.6 Switzerland Market Size and Forecast, by Application
      • 17.3.16.7 Switzerland Market Size and Forecast, by Form
      • 17.3.16.8 Switzerland Market Size and Forecast, by End User
      • 17.3.16.9 Switzerland Market Size and Forecast, by Device
      • 17.3.16.10 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Component
      • 17.3.17.6 Denmark Market Size and Forecast, by Application
      • 17.3.17.7 Denmark Market Size and Forecast, by Form
      • 17.3.17.8 Denmark Market Size and Forecast, by End User
      • 17.3.17.9 Denmark Market Size and Forecast, by Device
      • 17.3.17.10 Denmark Market Size and Forecast, by Mode
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Component
      • 17.3.18.6 Finland Market Size and Forecast, by Application
      • 17.3.18.7 Finland Market Size and Forecast, by Form
      • 17.3.18.8 Finland Market Size and Forecast, by End User
      • 17.3.18.9 Finland Market Size and Forecast, by Device
      • 17.3.18.10 Finland Market Size and Forecast, by Mode
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Component
      • 17.3.19.6 Russia Market Size and Forecast, by Application
      • 17.3.19.7 Russia Market Size and Forecast, by Form
      • 17.3.19.8 Russia Market Size and Forecast, by End User
      • 17.3.19.9 Russia Market Size and Forecast, by Device
      • 17.3.19.10 Russia Market Size and Forecast, by Mode
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.9 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Component
      • 17.4.9.6 China Market Size and Forecast, by Application
      • 17.4.9.7 China Market Size and Forecast, by Form
      • 17.4.9.8 China Market Size and Forecast, by End User
      • 17.4.9.9 China Market Size and Forecast, by Device
      • 17.4.9.10 China Market Size and Forecast, by Mode
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Component
      • 17.4.10.6 India Market Size and Forecast, by Application
      • 17.4.10.7 India Market Size and Forecast, by Form
      • 17.4.10.8 India Market Size and Forecast, by End User
      • 17.4.10.9 India Market Size and Forecast, by Device
      • 17.4.10.10 India Market Size and Forecast, by Mode
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Component
      • 17.4.11.6 Japan Market Size and Forecast, by Application
      • 17.4.11.7 Japan Market Size and Forecast, by Form
      • 17.4.11.8 Japan Market Size and Forecast, by End User
      • 17.4.11.9 Japan Market Size and Forecast, by Device
      • 17.4.11.10 Japan Market Size and Forecast, by Mode
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Component
      • 17.4.12.6 South Korea Market Size and Forecast, by Application
      • 17.4.12.7 South Korea Market Size and Forecast, by Form
      • 17.4.12.8 South Korea Market Size and Forecast, by End User
      • 17.4.12.9 South Korea Market Size and Forecast, by Device
      • 17.4.12.10 South Korea Market Size and Forecast, by Mode
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Component
      • 17.4.13.6 Australia Market Size and Forecast, by Application
      • 17.4.13.7 Australia Market Size and Forecast, by Form
      • 17.4.13.8 Australia Market Size and Forecast, by End User
      • 17.4.13.9 Australia Market Size and Forecast, by Device
      • 17.4.13.10 Australia Market Size and Forecast, by Mode
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Component
      • 17.4.14.6 Singapore Market Size and Forecast, by Application
      • 17.4.14.7 Singapore Market Size and Forecast, by Form
      • 17.4.14.8 Singapore Market Size and Forecast, by End User
      • 17.4.14.9 Singapore Market Size and Forecast, by Device
      • 17.4.14.10 Singapore Market Size and Forecast, by Mode
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Component
      • 17.4.15.6 Indonesia Market Size and Forecast, by Application
      • 17.4.15.7 Indonesia Market Size and Forecast, by Form
      • 17.4.15.8 Indonesia Market Size and Forecast, by End User
      • 17.4.15.9 Indonesia Market Size and Forecast, by Device
      • 17.4.15.10 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Component
      • 17.4.16.6 Taiwan Market Size and Forecast, by Application
      • 17.4.16.7 Taiwan Market Size and Forecast, by Form
      • 17.4.16.8 Taiwan Market Size and Forecast, by End User
      • 17.4.16.9 Taiwan Market Size and Forecast, by Device
      • 17.4.16.10 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Component
      • 17.4.17.6 Malaysia Market Size and Forecast, by Application
      • 17.4.17.7 Malaysia Market Size and Forecast, by Form
      • 17.4.17.8 Malaysia Market Size and Forecast, by End User
      • 17.4.17.9 Malaysia Market Size and Forecast, by Device
      • 17.4.17.10 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Component
    • 17.5.7 Latin America Market Size and Forecast, by Application
    • 17.5.8 Latin America Market Size and Forecast, by Form
    • 17.5.9 Latin America Market Size and Forecast, by End User
    • 17.5.10 Latin America Market Size and Forecast, by Device
    • 17.5.11 Latin America Market Size and Forecast, by Mode
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Component
      • 17.5.9.6 Brazil Market Size and Forecast, by Application
      • 17.5.9.7 Brazil Market Size and Forecast, by Form
      • 17.5.9.8 Brazil Market Size and Forecast, by End User
      • 17.5.9.9 Brazil Market Size and Forecast, by Device
      • 17.5.9.10 Brazil Market Size and Forecast, by Mode
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Component
      • 17.5.10.6 Mexico Market Size and Forecast, by Application
      • 17.5.10.7 Mexico Market Size and Forecast, by Form
      • 17.5.10.8 Mexico Market Size and Forecast, by End User
      • 17.5.10.9 Mexico Market Size and Forecast, by Device
      • 17.5.10.10 Mexico Market Size and Forecast, by Mode
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Component
      • 17.5.11.6 Argentina Market Size and Forecast, by Application
      • 17.5.11.7 Argentina Market Size and Forecast, by Form
      • 17.5.11.8 Argentina Market Size and Forecast, by End User
      • 17.5.11.9 Argentina Market Size and Forecast, by Device
      • 17.5.11.10 Argentina Market Size and Forecast, by Mode
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.9 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Component
      • 17.6.10.6 UAE Market Size and Forecast, by Application
      • 17.6.10.7 UAE Market Size and Forecast, by Form
      • 17.6.10.8 UAE Market Size and Forecast, by End User
      • 17.6.10.9 UAE Market Size and Forecast, by Device
      • 17.6.10.10 UAE Market Size and Forecast, by Mode
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Component
      • 17.6.11.6 South Africa Market Size and Forecast, by Application
      • 17.6.11.7 South Africa Market Size and Forecast, by Form
      • 17.6.11.8 South Africa Market Size and Forecast, by End User
      • 17.6.11.9 South Africa Market Size and Forecast, by Device
      • 17.6.11.10 South Africa Market Size and Forecast, by Mode
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Orexigen Therapeutics
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Vivus
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Arena Pharmaceuticals
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Zafgen
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Rhythm Pharmaceuticals
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Novo Nordisk
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Gelesis
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eisai Co Ltd
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Alizyme Therapeutics
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 NeuroSearch
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Sorrento Therapeutics
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Amgen
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Allergan
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Saniona
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 8i Ventures
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis